‘Making a difference’: White Paper on Dutch research for global TB elimination.

At the Annual Symposium ‘Innovation is everything’ KNCV presented a White Paper on Dutch Research for global TB elimination.

The Netherlands has a top position in research and innovation for TB. Several Dutch research institutes are among the world-leading groups in various aspects of TB research, owing to their expertise, research capacity, international networks and product innovation. Together they can make major contributions to the global TB research agenda. KNCV Tuberculosis Foundation and the Netherlands Tuberculosis Research Platform (NTRP) joined forces and brought together 21 research groups for an inventory process. The outcomes of this process are presented in the White Paper Dutch Research for global TB elimination.

Four specific areas of excellence in TB research were identified in which a collaborative Dutch effort brings major, cutting-edge value to the global END TB strategy. Dutch research groups have made, and will continue to make, internationally acclaimed contributions to research that will help accelerate the global elimination of TB.

The four areas of excellence identified are: fundamental scientific research into host-pathogen interaction; epidemiological research into understanding and reducing transmission; studying treatment optimization; and improving the health system response, including cost-effectiveness. In addition, Dutch researchers play important roles in building research capacity.

At the symposium the White Paper was presented to the Deputy Director of Science and Research, Mr. Michiel van den Hauten of the Netherlands Ministry of Education, Culture and Science (OCW).

Download the White Paper (pdf): Dutch Research for global TB elimination.

Read more on the 2015 Annual Symposium.

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.